EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation


Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation



Journal of Infection 54(3): 310-311



ISSN/ISBN: 0163-4453

PMID: 16545460

DOI: 10.1016/j.jinf.2006.01.019

This paper describes a case of Saccharomyces cerevisiae fungaemia in a 66-year-old woman with gastric adenocarcinoma, who underwent chemotherapy and surgical procedures involving multiple organs [Switzerland]. She also received a central venous catheter (CVC) for total parenteral nutrition. Thirteen days after receiving a new palliative chemotherapy cycle, she developed fever. Examination of peripheral and CVC blood cultures showed the growth of S. cerevisiae. Despite antifungal treatment, the patient died 2 months after the onset of fungaemia. The possibility of having contracted S. cerevisiae from a patient in the neighbouring room who was treated with a Saccharomyces boulardii (assumed to be a subtype of S. cerevisiae) powder for Clostridium difficile diarrhoea, is discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013044636

Download citation: RISBibTeXText

Related references

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 8(6): 504-505, 2000

Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 36(1): 41-43, 2003

Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Journal of Clinical Microbiology 41(11): 5340-5343, 2003

Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(4): 930, 2000

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Medicine 26(6): 825, 2000

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 40(11): 1635-1637, 2005

Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. American Journal of Medicine 105(1): 71-72, 1998

Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient. Revista Argentina de Microbiologia 52(1): 27-30, 2020

Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Medical Mycology Case Reports 15: 33-35, 2017

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Medical Mycology Case Reports 18: 15-17, 2017

Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation. Medical Mycology Case Reports 2: 63-64, 2013

Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration. Infectious Diseases now 51(3): 293-295, 2021

Saccharomyces boulardii fungemia in a patient with severe burns. Annales Francaises d'Anesthesie et de Reanimation 14(4): 356-358, 1995

Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities. Deutsche Medizinische Wochenschrift 128(48): 2531-2533, 2003

Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 27(1): 222-223, 1998